These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23181129)

  • 21. A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population.
    Eun YG; Hong IK; Kim SK; Park HK; Kwon S; Chung DH; Kwon KH
    Clin Exp Otorhinolaryngol; 2011 Sep; 4(3):149-54. PubMed ID: 21949582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients.
    Gu Y; Liu X; Yu Y; Shi J; Ai L; Sun H; Kanu JS; Wang C; Liu Y
    Int J Endocrinol; 2014; 2014():370825. PubMed ID: 25386189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of rs944289, rs965513, and rs1443434 in TITF1/TITF2 with Risks of Papillary Thyroid Carcinoma and with Nodular Goiter in Northern Chinese Han Populations.
    Zhang X; Gu Y; Li Y; Cui H; Liu X; Sun H; Yu Q; Yu Y; Liu Y; Zhan S; Cheng Y
    Int J Endocrinol; 2020; 2020():4539747. PubMed ID: 32104174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
    Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
    World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.
    Zhang S; Gao X; Wang Y; Jia J; Zhang Q; Ji Z
    Tumour Biol; 2015 Sep; 36(10):8207-11. PubMed ID: 25994572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single Nucleotide Polymorphism of Interleukin-18 and Interleukin-18 Receptor and the Risk of Papillary Thyroid Cancer.
    Chung JH; Lee YC; Eun YG; Chung JH; Kim SK; Chon S; Oh SJ; Rhee SY; Hong IK
    Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):598-603. PubMed ID: 26600055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma.
    Saljooghi S; Heidari Z; Saravani M; Rezaei M; Salimi S
    Rep Biochem Mol Biol; 2022 Jul; 11(2):216-223. PubMed ID: 36164628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma].
    Pei D; Xue G; Wu JF; Wang DM; Qin XJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
    Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
    J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
    Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
    Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
    Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
    Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association between promoter polymorphisms of HLA-G gene and rheumatoid arthritis in Korean population.
    Kim SK; Chung JH; Kim DH; Yun DH; Hong SJ; Lee KH
    Rheumatol Int; 2012 Feb; 32(2):509-12. PubMed ID: 21253738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.